Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-05-23
2006-05-23
Carlson, Karen Cochrane (Department: 1653)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
Reexamination Certificate
active
07049078
ABSTRACT:
Disclosed herein are methods for identifying a patient for the treatment of cognitive impairments.
REFERENCES:
patent: 5508167 (1996-04-01), Roses et al.
patent: 5576022 (1996-11-01), Yang et al.
patent: 5643960 (1997-07-01), Breitner et al.
patent: 5698224 (1997-12-01), Guittard et al.
patent: 5716828 (1998-02-01), Roses et al.
patent: 5767248 (1998-06-01), Roses et al.
patent: 5935781 (1999-08-01), Poirier
patent: WO 9409155 (1994-04-01), None
patent: WO 9529257 (1995-11-01), None
patent: WO 9602670 (1996-02-01), None
patent: WO 9603656 (1996-02-01), None
Poirier et al., Proc. Natl. Acad. Sci USA (1995) 92:12260-12264.
Bartus et al., “The Cholinergic Hypothesis of Geriatric Memory Dysfunction,” Science 217:408-417 (1982).
Brion, “The Neurobiology of Alzheimer's Disease,” Acta Clinica Belgica 51:80-90 (1996).
Corder et al., “Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families,” Science 261:921-923 (1993).
Davis et al., “Enhancement of Memory by Physostigmine,” N. Engl. J. Med. 301:946 (1979).
Davis et al., “A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's Disease,” N. Engl. J. Med. 327:1253-1259 (1992).
Farlow et al., “Apolipoprotein E Genotype and Gender Influence Response to Tacrine Therapy,” Annals New York Academy of Sciences pp. 101-110.
Higgins et al., “Apolipoprotein E and Alzheimer's Disease: A Review of Recent Studies,” Pharmacology Biochemistry and Behavior 56:675-685 (1997).
Knapp et al., “A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients with Alzheimer's Disease,” JAMA 271:985-991 (1994).
Liddell et al., “Confirmation of Association Between the E4 Allel of Apolipoprotein E and Alzheimer's Disease,” J. Medical Genetics 31:197-200 (1994).
Mahley et al., “Lipoprotein Receptors and Cholesterol Hemeostasis,” Biochim. Biophys. Acta. 737:197-222 (1983).
Main et al., “Apolipoprotein E Genotyping Using the Polymerase Chain Reaction and Allele-Specific Oligonucleotide Primers,” J. Lipid. Res. 32:183-187 (1991).
Nalbantoglu et al., “Predictive Value of Apolipoprotein E Genotyping in Alzheimer's Disease: Results of an Autopsy Series and an Analysis of Several Combined Studies,” Annals of Neurology 36:889-895 (1994).
Noguchi et al., “Apolipoprotein E Genotype and Alzheimer's Disease,” Lancet 342:737-738 (1993).
Payami et al., “Apolipoprotein E Genotype and Alzheimer's Disease,” Lancet 342:737-738 (1993).
Poirier et al., “Apolipoprotein E Polymorphism and Alzheimer's Disease,” Lancet 342:697-699 (1993).
Poirier et al., “Astrocytic Apolipoprotein E mRNA and GFAP mRNA in Hippocampus After Entorhinal Cortex Lesioning,” Molecular Brain Res. 11:97-106 (1991).
Poirier et al., “Astrological Gene Expression in the Hippocampus Following Partial Deafferentation in the Rat and in Alzheimer's Disease,” In: Basic, Clinical, and Therapeutic Aspects of Alzheimer's and Parkinson's Diseases, Basic and Therapeutic Strategies in Alzheimer's and Parkinson's Diseases, Plenum Press 1:191-194 (1990).
Poirier et al., “Cholesterol Synthesis and Lipoprotein Reuptake During Synaptic Remodelling in Hippocampus in Adult Rats,” Neuroscience 55:81-90 (1993).
Poirier et al., “Cloning of Hippocampal poly(A) RNA Sequences that Increase After Entorhinal Cortex Lesion in Adult Rat,” Mol. Brain Res. 9:191-195 (1991).
Roheim et al., “Apolipoproteins in Human Cerebrospinal Fluid,” Proc. Natl. Acad. Sci. USA 76:4646-4649 (1979).
Sorbi et al., “ApoE as a Prognostic Factor for Post-Traumatic Coma,” Nature Medicine 1:852 (1999).
Bieker-Brady Kristina
Carlson Karen Cochrane
Clark & Elbing LLP
Poirier Judés
LandOfFree
Apolipoprotein E polymorphism and treatment of alzheimer's... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apolipoprotein E polymorphism and treatment of alzheimer's..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apolipoprotein E polymorphism and treatment of alzheimer's... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3591265